It has dual inhibitory effects on phosphatidylinositol-3 kinase (PI3K)/Akt and the mammalian target rapamycin (mTOR) signaling in A549 human NSCLC cells and inhibits the cell viability and colony-forming ability of A549 cells [129]. The gene discussed is MTOR; the disease is non-small cell lung carcinoma.